Advertisement
Product › Details
Isoptin®
Next higher product group | verapamil (INN) | |
Status | 1994-01-01 sales existent | |
Status | 1997-01-01 sales existent | |
Organisation | Knoll AG | |
Today | AbbVie Deutschland GmbH & Co. KG, Ludwigshafen | |
Group | AbbVie (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cardiovascular drug
- [1] SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai....
- [2] Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel....
- [3] Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil....
- [4] Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel....
- [5] Idorsia Ltd.. (1/9/23). "Press Release: Idorsia Presents at the 41st J.P. Morgan Healthcare Conference – Achievements in 2022 Provide the Foundation for Our Success in 2023". Allschwil....
- [6] Vaderis Therapeutics AG. (8/22/22). "Press Release: Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT". Basel....
- [7] Mineralys Therapeutics, Inc.. (6/8/22). "Press Release: Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension". Philadeliphia, PA....
- [8] Vifor Pharma AG. (11/22/21). "Press Release: Vifor Pharma to Spearhead Development of Vascular Calcification Field, through Acquisition of Sanifit Therapeutics and Inositec AG". St. Gallen, Palma & Zurich....
- [9] Draupnir Bio ApS. (9/23/21). "Press Release: Draupnir Bio Establishes Scientific Advisory Board of International Experts in Cholesterol Metabolism and Cardiovascular Disease". Copenhagen....
- [10] Draupnir Bio ApS. (8/12/21). "Press Release: Draupnir Bio Expands Research Operations with New Facility at INCUBA Research Ppark". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top